Por Renan Filho · 2026-11-05
**Lead**
A convergence of underfunded pandemic preparedness programs, delayed animal health interventions, and political infighting has raised alarm among international health experts that the United States may inadvertently accelerate the emergence of a novel influenza strain with pandemic potential. The ongoing H5N1 avian influenza outbreak in American dairy cattle, first confirmed in March 2025, has already infected dozens of farm workers and shown worrying signs of mammalian adaptation. With the Trump administration’s reported cuts to the Centers for Disease Control and Prevention’s influenza surveillance network and a stalled federal response to contain the virus in livestock, the question is no longer whether the US can manage the threat on its own, but whether its failures will trigger a global crisis.
**Context**
Since early 2025, the H5N1 clade 2.3.4.4b virus has spread across dairy herds in at least 14 US states, with sporadic human cases linked to direct contact with infected animals. The World Health Organization has classified the current risk to the general public as low, but acknowledges that each human infection provides the virus an opportunity to mutate into a form capable of efficient human-to-human transmission. In October 2025, the US Department of Agriculture reported a significant uptick in H5N1 detections in commercial poultry flocks, further straining response resources.
Behind the scenes, however, political decisions have eroded the country’s ability to detect and contain such outbreaks. The Biden administration’s previous investments in pandemic preparedness were largely maintained into 2025, but the incoming administration of President Donald Trump, which took office in January 2026, has signalled a sharp shift. According to publicly available budget documents, the new administration proposed a 20 per cent reduction in the CDC’s influenza division budget and directed that remaining funds be prioritised for what officials called “domestic biodefence against deliberate threats,” implicitly downgrading natural outbreak surveillance. Several key positions in the US National Pandemic Task Force remain unfilled, and inter-agency coordination on animal-to-human disease spillover has been described by former officials as “paralysed.”
At the same time, the United States has historically been the largest contributor to the Global Influenza Surveillance and Response System (GISRS), a network of laboratories that shares genetic sequence data and virus samples with the WHO. In October 2026, the US government delayed its annual contribution to the WHO, citing an ongoing review of international health commitments. The move has raised fears that the timely sharing of H5N1 genetic data from US farms could be compromised, leaving other nations, including the United Kingdom, blind to emerging mutations.
**Analise**
The implications of a weakened US pandemic infrastructure extend far beyond American borders. The United Kingdom, which maintains close biosecurity ties with the US through the Five Eyes intelligence alliance and the UK Health Security Agency’s collaboration with the CDC, relies heavily on early warning data from North America to calibrate its own border health measures and vaccine strain selection. Any delay in detecting a more transmissible H5N1 variant in the US could give the virus a critical head start before the UK’s own surveillance systems pick it up.
Furthermore, the political instability in US health policy has a direct effect on the global vaccine supply chain. The UK has placed advance orders for a pandemic influenza vaccine based on the H5N1 strain, but the manufacturing capacity is tightly linked to American technology and raw material exports. If the US were to divert domestic vaccine production for its own needs in a crisis, British suppliers could face shortages. The UK’s own stockpile of antiviral drugs, while significant, is predicated on a scenario where the US rapidly contains any emerging pandemic at source—a scenario that now seems uncertain.
Beyond the immediate virological risk, the situation highlights a deeper geopolitical fragility: the assumption that the world’s most powerful nation can be relied upon to lead in global health security. The current administration’s scepticism toward multilateral institutions and its preference for bilateral, transactional health agreements have eroded trust among traditional allies. Several European governments have quietly begun reassessing their dependence on US-derived pandemic intelligence, and the UK’s National Security Council is reportedly reviewing contingency plans that assume a delayed or incomplete early warning from Washington.
**Fontes**
This article is based on publicly available budget proposals from the US Office of Management and Budget for fiscal year 2027, reports from the World Health Organization’s Global Influenza Programme, statements from the UK Health Security Agency regarding international surveillance cooperation, and press releases from the US Centers for Disease Control and Prevention concerning the H5N1 outbreak in dairy cattle. Further context was drawn from peer-reviewed analyses published in *The Lancet* and *Nature* during 2025–2026 on the mammalian adaptation of clade 2.3.4.4b. No individuals or organisations not explicitly named in these sources are cited as providing exclusive information.